Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2002
11/27/2002EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259505A2 Novel 1,3-dihydro-2h-indol-2-one, preparation method and pharmaceutical compositions containing same
11/27/2002EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002EP1259489A1 Aryl fused azapolycyclic compounds
11/27/2002EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002EP1259481A1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
11/27/2002EP1259477A1 Aminoadamantane derivatives as therapeutic agents
11/27/2002EP1259292A2 Therapeutic agents
11/27/2002EP1259260A1 Combination therapy for the treatment of inflammatory and respiratory diseases
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259243A2 Bupropion metabolites and methods of their synthesis and use
11/27/2002EP1259239A2 Use of cox-2 inhibitors as gastroprokinetics
11/27/2002EP1259233A1 Modulation of bone formation
11/27/2002EP1259128A1 Water containing soluble fiber
11/27/2002EP1259125A1 Inulin products with improved nutritional properties
11/27/2002EP1073639B1 Quinoline derivatives
11/27/2002EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002EP0920330B1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
11/27/2002EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382154A Basic monocyclic compounds having NK2 antagonist action processes for their preparation and formulations containing them
11/27/2002CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382138A Piperidine derivatives as reuptake inhibitors
11/27/2002CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002CN1382048A Formulation of substituted benzimidazoles
11/27/2002CN1381562A Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
11/27/2002CN1381556A Xingshi wine-for tonifying kidney and strengthening yang
11/27/2002CN1381465A Gene configuration, preparing process and usage of antibacterial peptide
11/27/2002CN1381463A Magnesium isoglycyrrhetate and its preparing process and usage
11/27/2002CN1381461A Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application
11/27/2002CN1381456A Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
11/27/2002CN1381265A Medicine for treating cholecystitis and its preparing process
11/27/2002CN1381259A Medicine for treating diseases of rectum and anus
11/27/2002CN1381250A Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis
11/27/2002CN1381247A Health-care oral liquid
11/27/2002CN1094762C Fresh rehmannia root extract for proliferation of bifidobactor and extraction method thereof
11/26/2002US6486205 Mixture of primary fatty acids obtained from sugar cane wax
11/26/2002US6486190 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
11/26/2002US6486186 Thiazole compounds as cyclic AMP-specific phosphodiesterase inhibitors and method of using the same
11/26/2002US6486144 Method of treatment of liver tumors and pharmaceutical compositions for use therein
11/26/2002US6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002US6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002US6486122 Methods of increasing body weight in a subject by administering TGF-α
11/26/2002US6485755 Methods of using electron active compounds for managing cancer
11/26/2002CA2258285C Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
11/26/2002CA2228635C Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
11/26/2002CA2111573C Cadherin materials and methods
11/26/2002CA2100864C Method for delivering direct feed microorganisms to poultry in ovo
11/22/2002WO2001090079A2 Novel carbamates and carbamides, production and use thereof as endothelin receptor antagonists
11/22/2002CA2410304A1 Novel carbamates and ureas production and use thereof as endothelin receptor antagonists
11/21/2002WO2002093176A2 Methods for identifying compounds for treatment of ibd
11/21/2002WO2002092849A2 Methods
11/21/2002WO2002092841A2 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002WO2002092827A2 Corona-virus-like particles comprising functionally deleted genomes
11/21/2002WO2002092781A2 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002WO2002092762A2 Cytokine polypeptides
11/21/2002WO2002092759A2 Molecules for disease detection and treatment
11/21/2002WO2002092758A2 Gastrokines and derived peptides including inhibitors
11/21/2002WO2002092756A2 Insulin producing cells derived from human embryonic stem cells
11/21/2002WO2002092667A1 Biodegradable polyphosphates for controlled release of bioactive substances
11/21/2002WO2002092604A1 1-oxa-3,9-diaza-spiro'5,5!undecan-2-ones derivatives and its use as antagonist of the neurikinin receptor
11/21/2002WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002WO2002092592A1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method and intermediate products for the production thereof and medicament containing said compounds
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092563A2 Protease inhibitors
11/21/2002WO2002092558A1 Polythiourea lipid derivatives
11/21/2002WO2002092550A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002WO2002092116A1 Targeted delivery of drugs for the treatment of viral infections
11/21/2002WO2002092106A1 Taste masking pharmaceutical composition
11/21/2002WO2002092090A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002WO2002092067A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/21/2002WO2002092064A2 Therapeutic method for inducing tolerance
11/21/2002WO2002092049A2 System for delivering cosmetics and pharmaceuticals
11/21/2002WO2002092039A1 Methods for treating or preventing diseases of the oral cavity
11/21/2002WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002WO2002092013A2 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002WO2002092006A2 Nucleic acid-based compounds and methods of use thereof
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
1 ... 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 ... 1258